Please try another search
Pz Wind Down, Inc., formerly, PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Company's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The Company's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The Company is headquartered in Seattle.
Name | Age | Since | Title |
---|---|---|---|
Peggy V. Phillips | 68 | 2016 | Director |
Steven S. Gillis | 69 | 2008 | Chairman |
Robert W. Overell | 66 | 2006 | Co-Founder, CEO, President, Principal Accounting Officer, Secretary & Director |
Paul H. Johnson | 79 | 2007 | Co-Founder & Director |
Brian G. Atwood | 69 | 2008 | Director |
John A. Schmidt | 71 | 2010 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review